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Objectives This study was designed to determine whether multislice computed tomography (MSCT) coronary angiography
has incremental prognostic value over single-photon emission computed tomography myocardial perfusion im-
aging (MPI) in patients with suspected coronary artery disease (CAD).
Background Although MSCT is used for the detection of CAD in addition to MPI, its incremental prognostic value is unclear.
Methods In 541 patients (59% male, age 59  11 years) referred for further cardiac evaluation, both MSCT and MPI were
performed. The following events were recorded: all-cause death, nonfatal infarction, and unstable angina requir-
ing revascularization.
Results In the 517 (96%) patients with an interpretable MSCT, significant CAD (MSCT 50% stenosis) was detected in
158 (31%) patients, and abnormal perfusion (summed stress score [SSS]: 4) was observed in 168 (33%) pa-
tients. During follow-up (median 672 days; 25th, 75th percentile: 420, 896), an event occurred in 23 (5.2%) pa-
tients. After correction for baseline characteristics in a multivariate model, MSCT emerged as an independent
predictor of events with an incremental prognostic value to MPI. The annualized hard event rate (all-cause mor-
tality and nonfatal infarction) in patients with none or mild CAD (MSCT 50% stenosis) was 1.8% versus 4.8% in
patients with significant CAD (MSCT 50% stenosis). A normal MPI (SSS 4) and abnormal MPI (SSS 4) were
associated with an annualized hard event rate of 1.1% and 3.8%, respectively. Both MSCT and MPI were syner-
gistic, and combined use resulted in significantly improved prediction (log-rank test p value 0.005).
Conclusions MSCT is an independent predictor of events and provides incremental prognostic value to MPI. Combined ana-
tomical and functional assessment may allow improved risk stratification. (J Am Coll Cardiol 2009;53:
623–32) © 2009 by the American College of Cardiology Foundation
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Prognostic Value of MSCT and Gated SPECT February 17, 2009:623–32With the arrival of multislice com-
puted tomography coronary an-
giography (MSCT), the focus of
noninvasive imaging has shifted
from functional imaging to a
combination of both anatomical
and functional imaging. Several
studies (1–3) have addressed the
association between the anatom-
ical and functional information
obtained with MSCT and myo-
cardial perfusion imaging (MPI)
using single-photon emission
computed tomography (SPECT),
respectively. These comparative
studies have shown that MSCT
may provide complementary
rather than overlapping diagnos-
ic information when used in combination with MPI.
hether MSCT provides complementary information to
PI with regard to risk stratification remains to be deter-
ined. Interestingly, studies in the past have shown that
PI provides substantial incremental value over anatomical
nformation obtained with invasive coronary angiography.
owever, no studies have addressed this issue more recently
4,5). Moreover, MSCT may have an important advantage
ver invasive coronary angiography due to its ability to
rovide information on plaque composition in addition to
tenosis severity (6). Accordingly, the information obtained
y MSCT may potentially enhance risk stratification by
PI. The aim of this study was therefore to assess in
atients presenting with suspected coronary artery disease
CAD) whether MSCT has incremental prognostic value
ver MPI.
ethods
atient selection. The study population consisted of 541
atients who prospectively underwent both MPI and
SCT within 3 months of each other. Enrollment of
atients started in June 2003 and continued until December
007. Follow-up information was obtained from the start of
he study until August 2008. Patients were included at the
niversity Hospital in Zurich, Switzerland (n  269); the
ardiovascular Center in Aalst, Belgium (n  17); and at
he Leiden University Medical Center in Leiden, the
etherlands (n  255). Patients were referred because of
hest pain complaints, a positive exercise electrocardiogram
ECG) test, or a high-risk profile for cardiovascular disease.
xclusion criteria were cardiac arrhythmias, renal insuffi-
iency (serum creatinine 120 mmol/l), known hypersen-
itivity to iodine contrast media, and pregnancy. In addition,
atients with a cardiac event in the period between MSCT
nd MPI or an uninterpretable MSCT scan were excluded.
he pre-test probability of CAD was determined using the
Abbreviations
and Acronyms
CAD  coronary artery
disease
CS  coronary artery
calcium score
ECG  electrocardiogram
MPI  myocardial perfusion
imaging
MSCT  multislice
computed tomography
coronary angiography
SPECT  single-photon
emission computed
tomography
SSS  summed stress
scoreiamond and Forrester method, as previously described (7). She study was approved by the local ethics committees in all
participating centers, and informed consent was obtained
rom all patients.
PI. MPI was performed using gated SPECT. Two
CG-gated MPI protocols were used. A total of 272
atients underwent a 2-day gated stress-rest MPI using
echnetium (Tc) 99m tetrofosmin (500 MBq) or Tc 99m
estamibi (500 MBq) with either a symptom-limited bicycle
est or pharmacological stress using adenosine (140 g/kg/
in for 6 min) or dobutamine (up to 40 g/kg/min in 15
in). The remaining 269 patients underwent a 1-day
tress-rest protocol with adenosine stress (140 g/kg/min
uring 7 min) using Tc 99m tetrofosmin (300 MBq at peak
tress and 900 MBq at rest).
The images were acquired on a triple-head SPECT
amera (GCA 9300/HG, Toshiba Corp., Tokyo, Japan) or
dual-head detector camera (Millennium VG & Hawkeye,
eneral Electric Medical Systems, Milwaukee, Wisconsin;
r Vertex Epic ADAC Pegasus, Philips Medical Systems,
indhoven, the Netherlands). All cameras were equipped
ith low-energy high-resolution collimators. A 20% win-
ow was used around the 140-keV energy peak of Tc 99m,
nd data were stored in a 64  64 matrix.
Stress and rest SPECT perfusion datasets were quanti-
atively evaluated using previously validated automated soft-
are (8). The myocardium was divided into a 20-segment
odel, and for each segment, myocardial perfusion was
valuated using a standard 5-point scoring system. The
egmental perfusion scores during stress and rest were added
ogether to calculate the summed stress score (SSS) and the
ummed rest score. The summed difference score was
alculated by subtracting the summed rest score from the
SS. Abnormal MPI was defined as SSS 4 and severely
bnormal MPI was defined as SSS 8.
SCT. In 33 patients, the MSCT examination was per-
ormed using a 16-slice scanner (Aquillion16, Toshiba
edical Systems, Tokyo, Japan). The remaining 508 (94%)
atients were scanned using a 64-slice MSCT scanner
Aquillion64, Toshiba Medical Systems, Tokyo, Japan;
eneral Electric LightSpeed VCT, Milwaukee, Wisconsin;
r Sensation64, Siemens, Forchheim, Germany). The pa-
ient’s heart rate and blood pressure were monitored before
ach scan. In the absence of contraindications, patients with
heart rate exceeding the threshold of 65 beats/min were
dministered beta-blocking medication (50- to 100-mg
etoprolol, oral, or 5- to 10-mg metoprolol, intravenous).
Before the helical scan, a nonenhanced low-dose prospec-
ive ECG-gated scan, prospectively triggered at 75% of the
-R interval, was performed to measure the coronary artery
alcium score (CS). The helical scan parameters have been
reviously described (3,9).
Post-processing of the MSCT and CS scans was per-
ormed on dedicated workstations (Vitrea2, Vital Images,
inneapolis, Minnesota; Advantage, GE Healthcare, St.
iles, United Kingdom; Syngo InSpace4D application,iemens, Munich, Germany; and Aquarius, TeraRecon,
S
A
s
i
A
e
d
i
t
P
(
l
m
a
F
o
u
T
a
u
t
e
E
p
w
n
c
w
e
w
S
a
d
r
v
a
v
a
r
(
U
n
c
c
T
v
c
a
m
n
l
m
p
C
I
e
R
P
p
p
w
h
u
(
(
p
b
T
y
p
p
p
M
f
w
d
i
w
M
s
p
r
M
3
(
(
a
(
p
(
s
P
625JACC Vol. 53, No. 7, 2009 van Werkhoven et al.
February 17, 2009:623–32 Prognostic Value of MSCT and Gated SPECTan Mateo, California). The CS was calculated using the
gatston method. Coronary anatomy was assessed in a
tandardized manner by dividing the coronary artery tree
nto 17 segments according to the modified American Heart
ssociation classification. For each segment, both the pres-
nce of atherosclerotic plaque as well as its composition was
etermined. Atherosclerotic lesions were deemed significant
f the diameter stenosis was 50%. Lesions below this
hreshold were considered to be nonsignificant or mild.
laque composition was graded as noncalcified plaque
plaques having lower density than the contrast-enhanced
umen), calcified plaque (plaques with high density), and
ixed plaque (containing elements from both noncalcified
nd calcified plaque).
ollow-up. Patient follow-up data were gathered by 3
bservers blinded to the baseline MSCT and MPI results
sing clinical visits or standardized telephone interviews.
he following events were regarded as clinical end points:
ll-cause mortality, nonfatal myocardial infarction, and
nstable angina requiring revascularization. Nonfatal infarc-
ion was defined based on criteria of typical chest pain,
levated cardiac enzyme levels, and typical changes on the
CG. Unstable angina was defined according to the Euro-
ean Society of Cardiology guidelines as acute chest pain
ith or without the presence of ECG abnormalities, and
egative cardiac enzyme levels (10). Patients with stable
omplaints undergoing an early elective revascularization
ithin 60 days after imaging with MSCT or MPI were
xcluded from the survival analysis. Annualized event rates
ere calculated based on events per patient year follow-up.
tatistical analysis. Continuous variables were expressed
s mean and standard deviation, and categorical baseline
ata were expressed in numbers and percentages. Cox
egression analysis was used to determine the prognostic
alue of CS, MSCT, and MPI variables. First, univariate
nalysis of baseline characteristics, CS, MSCT, and MPI
ariables was performed using a composite end point of
ll-cause mortality, nonfatal infarction, and unstable angina
equiring revascularization. For each variable, a hazard ratio
HR) with a 95% confidence interval (CI) was calculated.
sing univariate analysis, optimal cutoffs (based on the
umber of segments affected) were created for plaque
omposition on MSCT. Finally, multivariate models were
reated correcting MSCT and MPI for baseline risk factors.
he incremental value of MSCT over baseline clinical
ariables and MPI was assessed by calculating the global
hi-square test.
Cumulative event rates for MSCT, MPI, and for MSCT
nd MPI combined were obtained by the Kaplan-Meier
ethod using a composite end point of all-cause mortality,
onfatal infarction, and unstable angina requiring revascu-
arization, and a hard composite end point of all-cause
ortality and nonfatal infarction. Statistical analyses were
erformed using SPSS software, version 12.0 (SPSS Inc,
hicago, Illinois) and the SAS system 6.12 (SAS Institute Bnc., Cary, North Carolina). A p value 0.05 was consid-
red statistically significant.
esults
atient characteristics. In the study population of 541
atients, an uninterpretable MSCT examination was
resent in 24 patients (4%). Reasons for uninterpretability
ere the presence of motion artifacts, increased noise due to
igh body mass index, and breathing. In patients with an
ninterpretable MSCT, MPI was abnormal (SSS 4) in 9
38%) patients and normal (SSS 4) in the remaining 15
62%) patients. After exclusion of these patients, 517
atients remained for analysis. A complete overview of the
aseline characteristics of these patients is presented in
able 1. The average age of the study cohort was 59  11
ears, and 59% of patients were men. The majority of
atients (65%) presented with an intermediate pre-test
robability for CAD, and a low or a high probability was
resent in, respectively, 22% and 13% of patients.
SCT and SPECT results. An exercise test was per-
ormed in 88 patients (17%), while a pharmacological stress
ith adenosine was used in 397 patients (77%) and with
obutamine in 30 patients (6%). All MPI results are listed
n Table 2. The gated SPECT images during rest and stress
ere normal (SSS 4) in 349 (67%) patients. An abnormal
PI (SSS 4) was present in 192 (33%) patients and
everely abnormal MPI (SSS 8) was present in 64 (13%)
atients. During MSCT image acquisition, an average heart
ate of 63  11 beats/min was recorded. The CS and
SCT results are listed in Table 2. The average CS was
25  751 Agatston units. A CS 400 was present in 113
22%) patients, and CS was normal or400 in 404 patients
78%). A CS 1,000 was observed in 47 (9%) patients, but
CS 1,000 was observed in the remaining 470 patients
91%). During the contrast-enhanced helical scan, a com-
letely normal MSCT examination was observed in 155
30%) of patients. Atherosclerosis, both mild (50% steno-
is) and significant (50% stenosis), was observed in 362
atient Characteristics
Table 1 Patient Characteristics
Total (n  517)
Male 303 (59%)
Age, yrs 59  11
Risk factors
Diabetes 156 (30%)
Hypertension 290 (56%)
Hypercholesterolemia 209 (40%)
Family history of CAD 191 (37%)
Current smoking 154 (30%)
Obesity (BMI 30 kg/m2) 111 (22%)
Pre-test likelihood of CAD
Low 113 (22%)
Intermediate 336 (65%)
High 68 (13%)MI  body mass index; CAD  coronary artery disease.
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Prognostic Value of MSCT and Gated SPECT February 17, 2009:623–3270%). Significant CAD with lesions 50% stenosis was
bserved in 158 (31%) patients. Noncalcified plaques were
bserved in 130 patients (25%), mixed plaques in 204
atients (40%), and calcified plaques in 270 patients (52%).
The results of MSCT in relation to MPI are illustrated in
igure 1. This figure illustrates the complementary value of
SCT and MPI. Only approximately 50% of patients with
Figure 1 Anatomic Information From MSCT and Functional Info
Pie charts depicting the relationship between the anatomic information obtained b
CAD  coronary artery disease; MPI  myocardial perfusion imaging; MSCT  mu
maging Results
Table 2 Imaging Results
Patients (%)
CS
400 113 (22%)
1,000 47 (9%)
MSCT
Atherosclerosis 362 (70%)
Significant CAD 158 (31%)
Patients with noncalcified plaques 130 (25%)
Patients with mixed plaques 204 (40%)
Patients with calcified plaques 270 (52%)
MPI
SSS 4 (normal) 349 (67%)
SSS 4–7 104 (20%)
SSS 8–12 44 (9%)
SSS 13 20 (4%)
SDS 0–1 378 (73%)
SDS 2–3 72 (14%)
SDS 4 67 (13%)
AD  coronary artery disease; CS  coronary artery calcium score; MPI  myocardial perfusion
maging; MSCT  multislice computed tomography coronary angiography; SDS  summed
ifference score; SSS  summed stress score.significant lesion (50% stenosis) showed a perfusion
efect on MPI (SSS4). Importantly, a significant stenosis
as observed in 22% of patients with normal perfusion on
PI (SSS 4).
ollow-up results. Of the cohort of 517 patients, 35
6.8%) were lost to follow-up, and 43 (8.3%) patients
nderwent early revascularization (within 60 days of MSCT
r MPI). In the remaining 439 patients, the median
ollow-up time achieved was 672 days (25th, 75th percen-
ile: 420, 896). During this period, an event occurred in 23
atients (5.2%). Death by any cause occurred in 8 patients
1.8%); in 2, the cause of death could be ascertained as
ardiac. Nonfatal myocardial infarction occurred in 8 pa-
ients (1.8%), and 7 patients (1.6%) were hospitalized due to
nstable angina pectoris.
nivariate and multivariate analysis. Baseline univariate
redictors of events are listed in Table 3. This study found
S, MSCT coronary angiography, and MPI were signifi-
ant univariate predictors of events. Both CS 400 and CS
1,000 were significant predictors. When regarding the
SCT results on a patient level, the presence of significant
AD (50% stenosis) was a strong significant predictor
HR: 3.683, 95% CI: 1.611 to 8.420), whereas the presence
f any atherosclerosis was not (HR: 3.087, 95% CI: 0.917 to
0.388). Importantly, plaque composition on MSCT was
lso identified as a predictor of events. On a patient level,
he presence of 2 segments with noncalcified plaque (n 
5) (HR: 5.0, 95% CI: 2.2 to 11.7) or 3 segments with
ixed plaque (n  68) (HR: 3.5, 95% CI: 1.5 to 8.1) were
ion From MPI
T and the functional information from MPI.
computed tomography coronary angiography; SSS  summed stress score.rmat
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February 17, 2009:623–32 Prognostic Value of MSCT and Gated SPECToth significant predictors of events. Of the MPI variables,
he SSS 4 was the strongest significant predictor of events
HR: 4.0, 95% CI: 1.7 to 9.3).
After univariate analysis, multivariate models were cre-
ted for both MSCT and MPI correcting for baseline risk
actors. MSCT (50% stenosis) remained a significant
redictor when corrected for CS 400 or CS 1,000.
owever, CS400 and CS1,000 did not reach statistical
ignificance. Myocardial perfusion imaging also remained a
ignificant predictor when corrected for CS 400 or CS
1,000. In this model, CS1,000, however, also remained
significant independent predictor of events.
Figure 2 Incremental Prognostic Value of MSCT
Bar graph illustrating the incremental prognostic value (depicted by chi-square valu
mation to baseline clinical variables and MPI. Furthermore, the addition of noncalc
mental prognostic information over baseline clinical variables, MPI, and significant
nivariate Predictors of Events
Table 3 Univariate Predictors of Events
HR (95% CI) p Value
CS
400 3.007 (1.318–6.860) 0.009
1,000 3.752 (1.392–10.114) 0.009
MSCT
Atherosclerosis 3.087 (0.917–10.388) 0.069
Significant CAD 3.683 (1.611–8.420) 0.002
2 noncalcified plaques 5.0 (2.2–11.7) 0.001
3 mixed plaques 3.5 (1.5–8.1) 0.005
4 calcified plaques 1.5 (0.6–4.1) 0.409
MPI
SSS 2 3.500 (1.513–8.094) 0.003
SSS 4 4.029 (1.742–9.319) 0.001
SSS 8 1.922 (0.653–5.656) 0.236
SDS 2 1.853 (0.783–4.381) 0.160
SDS 4 2.142 (0.724–6.336) 0.169
I  confidence interval; HR  hazard ratio; other abbreviations as in Table 2.Subsequently, several multivariate models were created to
ssess the independent predictive value of different MSCT
ariables, corrected for MPI and baseline risk factors. On a
atient level, no independent prognostic value over MPI
nd baseline risk factors was observed for the presence of
ny atherosclerosis on MSCT. In contrast, the observation
f significant CAD on MSCT was shown to provide
ndependent prognostic value over MPI. When regarding
laque composition, only the presence of 2 or more seg-
ents with noncalcified plaque was an independent signif-
cant predictor. Importantly, MPI remained an independent
ignificant predictor of events in each multivariate model.
To assess the incremental prognostic value of these
SCT variables over baseline clinical variables and MPI,
lobal chi-square scores were calculated. The results of this
nalysis are presented in Figure 2. This figure shows that
nformation on the presence of significant stenosis obtained
y MSCT has incremental prognostic value to both baseline
linical variables alone and baseline clinical variables and
PI combined. Finally, the addition of noncalcified plaque
n a patient basis resulted in further enhancement of risk
tratification incremental to the combination of clinical
ariables, MPI, and significant stenosis on MSCT.
vent rates. The Kaplan-Meier survival curves in Figures 3
nd 4 illustrate the different survival rates of the MPI and
SCT test outcomes both for the composite end point of
ll-cause mortality, nonfatal myocardial infarction, and
nstable angina requiring revascularization (log-rank test
 0.001), as well as for the combined hard end point of
ll-cause mortality and nonfatal myocardial infarction (log-
ank test p  0.05). The annualized event rate (annualized
he y axis) of MSCT. The addition of MSCT provides incremental prognostic infor-
laque on MSCT (2 segments with noncalcified plaque) results in further incre-
50% stenosis) on MSCT. Abbreviations as in Figure 1.e on t
ified p
CAD (
e
w
t
(
p
w
i
a
w
a
(
p
w
(

c
o
(
s
C
(
r
o
M
i
C
(
3
w
M
s
s
M
9
628 van Werkhoven et al. JACC Vol. 53, No. 7, 2009
Prognostic Value of MSCT and Gated SPECT February 17, 2009:623–32vent rate for hard events between parentheses) in patients
ith a normal MPI examination (SSS4) was 1.5% (1.1%);
he annualized event rate in patients with an abnormal MPI
SSS 4) was 6.0% (3.8%). The annualized event rate in
atients with none or mild CAD (MSCT 50% stenosis)
as 3.0% (1.8%). When these patients were further divided
nto patients with mild atherosclerosis and patients without
ny evidence of atherosclerosis, the annualized event rates
ere 2.0% (1.4%) and 1.1% (0.3%), respectively. The
nnualized event rate for patients with a significant stenosis
50%) on MSCT was 6.3% (4.8%). When regarding
laque composition, the annualized event rate in patients
ith 2 or more segments with noncalcified plaque was 8.4%
6.7%) compared with 1.9% (1.2%) in patients with no or
2 segments with noncalcified plaque.
Combined use of MSCT and MPI resulted in signifi-
antly improved prediction of the composite hard end point
Figure 3 Event-Free Survival in Patients With a Normal MPI (SS
(A) Kaplan-Meier curves for all events (all-cause mortality, nonfatal infarction, and
an abnormal MPI (SSS 4). (B) Kaplan-Meier curves for hard events (all-cause mo
MPI (SSS 4). Abbreviations as in Figure 1.f all-cause mortality and nonfatal myocardial infarction clog-rank test p 0.005), as illustrated in the Kaplan-Meier
urvival curve in Figure 5. In patients with none or mild
AD (MSCT50% stenosis) and a normal MPI (SSS4)
n  256), the annualized event rate (annualized hard event
ate in parenthesis) was 1.0% (0.6%). In patients with none
r mild CAD (MSCT 50% stenosis) but an abnormal
PI (SSS 4) (n  72), the annualized event rate
ncreased to 3.7% (2.2%), whereas patients with significant
AD (MSCT50% stenosis) and a normal MPI (SSS4)
n  57) were associated with an annualized event rate of
.8% (3.8%). Interestingly, the event rates between patients
ith none or mild CAD (50%) stenosis and an abnormal
PI and patients with significant CAD (MSCT 50%
tenosis) did not differ significantly. In patients with both
ignificant CAD (MSCT 50% stenosis) and an abnormal
PI (SSS 4) (n  54), the annualized event rate was
.0% (6.0%). In these patients, the addition of plaque
4) or an Abnormal MPI (SSS >4)
ble angina requiring revascularization) in patients with a normal MPI (SSS 4) or
and nonfatal infarction) in patients with a normal MPI (SSS 4) or an abnormalS <
unsta
rtalityomposition (the presence of 2 or more segments with
n
r
D
T
c
m
p
i
R
p
M
l
a
d
(
f
p
(
a
a
h
t
l
i
w
R
n
a
(
l
c
i
0
c
o
629JACC Vol. 53, No. 7, 2009 van Werkhoven et al.
February 17, 2009:623–32 Prognostic Value of MSCT and Gated SPECToncalcified plaque [n  20]) resulted in the highest event
ate, 10.8% (8.2%).
iscussion
he main finding of the current study is that when used in
ombination with MPI, MSCT not only provides comple-
entary information about the presence, extent, and com-
osition of atherosclerosis, but importantly, also results in
mproved risk stratification than the use of MPI alone.
isk stratification with MPI. A wealth of data has been
ublished on the diagnostic accuracy and prognostic value of
PI (11–16). In an extensive review of the available
iterature, a low-risk scan was associated with a low annu-
lized hard event rate (cardiac death and nonfatal myocar-
ial infarction) of 0.6% in a population of 69,655 patients
17). In a recent meta-analysis, Metz et al. (18) specifically
ocused on the prognostic value of a normal MPI. The
Figure 4 Event-Free Survival in Patients With No CAD (MSCT N
Mild CAD (MSCT <50% Stenosis), or Significant CAD
(A) Kaplan-Meier curves for all events (all-cause mortality, nonfatal infarction, and
mild CAD (MSCT 50% stenosis), or significant CAD (MSCT 50% stenosis). (B)
patients with no CAD (MSCT normal), mild CAD (MSCT 50% stenosis), or significooled summary absolute event rate in their study was 1.21 a95% CI: 0.98 to 1.48) for the occurrence of cardiac death
nd nonfatal myocardial infarction. The slightly higher
bsolute hard event rate in the current study (2.2%) may
ave been caused by the inclusion of all-cause mortality and
he fact that the majority of patients underwent pharmaco-
ogical testing (17,19). Importantly, event rates were signif-
cantly higher in patients with abnormal MPI (SSS 4),
hich is in line with the previous studies (17).
isk stratification with MSCT. Although MSCT coro-
ary angiography is a relatively new technique, a consider-
ble amount of evidence is available with calcium scoring
20–27). Moreover, in a systematic review of the available
iterature (n  27,622 patients), the presence of any
oronary artery calcium was shown to confer a 4-fold
ncreased risk of cardiac death or myocardial infarction (p
.0001) compared with the absence of coronary artery
alcifications (24). In contrast, an extremely low event rate
f 0.4% was observed in patients without any coronary
l),
CT >50% Stenosis)
ble angina requiring revascularization) in patients with no CAD (MSCT normal),
-Meier curves for hard events (all-cause mortality and nonfatal infarction) in
D (MSCT 50% stenosis). Abbreviations as in Figure 1.orma
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f anatomic imaging with MSCT coronary angiography
28–30). In the present study, annual hard event rates of 0.3%,
.0%, and 4.8% were observed in patients with completely
ormal, nonsignificant, and significant CAD on MSCT,
espectively. Min et al. (29) evaluated 1,127 patients under-
oing 16-slice MSCT with a mean follow-up of 15.3  3.9
onths. In line with our study, event rates for all-cause
ortality ranging between 0.3% for none or mild athero-
clerosis (stenosis 50%) and 15% for mild to moderate left
ain disease were observed in a period of 2 years.
Currently, 1 previous study by Pundziute et al. (30) has
ddressed the prognostic value of plaque components as-
essed by MSCT. The number of mixed plaques was a
ignificant predictor when corrected for baseline clinical
ariables. In the current study, only noncalcified plaque
emained an independent predictor of events. The discrep-
ncy between the current results and the study by Pundziute
t al. (30) may be explained by differences in the studied
atient populations as well as the use of optimized cutoffs
nd correction for MPI results in the current study.
ombination of MSCT and MPI. In previous studies,
he prognostic value of anatomic imaging using calcium
coring in relation to MPI has been addressed (31–34).
ecently, Schenker et al. (34) showed that the risk of
ll-cause mortality and myocardial infarction increased with
ncreasing CS, both in patients with normal and in patients
ith abnormal perfusion on MPI. The present study is the
rst to address the incremental prognostic value of MSCT
hen used in combination with MPI. Previous studies have
hown that MPI provides incremental prognostic informa-
ion over invasive coronary angiography (4,5). Vice versa,
he current study has revealed that the anatomic informa-
ion on MSCT is not only an independent predictor of
vents but also provides incremental prognostic information
Figure 5 Kaplan-Meier Curves for Hard Events in Patients With
Kaplan-Meier curves for hard events (all-cause mortality and nonfatal infarction) in
MSCT, in patients with an abnormal MPI (SSS 4) and with none or mild CAD (5
(MSCT 50% stenosis), and finally, in patients with an abnormal MPI (SSS 4) anver baseline clinical variables and MPI, particularly in natients with a normal MPI. Although several MSCT
ariables were able to provide prognostic information, on a
atient level the presence of significant CAD (50%
tenosis) was identified as a robust independent predictor.
his is an important finding, as diagnostic MSCT exami-
ations are often graded in this manner. In addition to
tenosis severity, plaque composition was also identified to
urther enhance risk stratification. Indeed, the presence of
oncalcified plaques provided incremental prognostic infor-
ation over baseline clinical variables, MPI, and significant
AD on MSCT. This finding suggests that potentially
ssessment of plaque composition on MSCT may provide
linically relevant information in addition to stenosis
everity.
tudy limitations. Even though the diagnostic accuracy of
SCT is high, images are still uninterpretable in a small
ercentage of patients. It is, however, anticipated that the
mount of uninterpretable studies will continue to decrease
ith newer-generation scanners (35,36). In contrast, none
f the SPECT examinations were uninterpretable in this
tudy.
Another potential limitation is that the MSCT studies
ere evaluated visually; no validated accurate quantitative
lgorithms are currently available. In the current study, a
omposite end point including all-cause mortality was used,
hich is not a direct cardiac end point. An important
dvantage of all-cause mortality, however, is the fact that it
s not affected by verification bias (37). Furthermore, most
eaths in adults are linked to cardiovascular disease. All-
ause mortality is therefore a commonly used end point
llowing comparison of the current results to previous
nvestigations (21,26,29,34). Finally, the radiation burden as-
ociated with combined MSCT and MPI imaging is a limi-
ation. However, the radiation dose can decrease significantly
hen using dedicated dose reduction MSCT acquisition tech-
rmal or Abnormal MPI and With or Without CAD
ts with a normal MPI (SSS 4) and none or mild CAD (50% stenosis) on
enosis) on MSCT, in patients with a normal MPI (SSS 4) and significant CAD
ificant CAD (MSCT 50% stenosis). Abbreviations as in Figure 1.a No
patien
0% st
d signiques that have recently become available (38–41).
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SCT is an independent predictor of events and provides
ncremental prognostic value to MPI. Furthermore, addi-
ion of plaque composition to stenosis severity was shown to
rovide incremental prognostic information. The results of
his study suggest that combined anatomical and functional
ssessment may allow improved risk stratification.
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